Search Results - "Karjalainen, Pasi P"

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry by Proietti, Marco, Airaksinen, K.E. Juhani, Rubboli, Andrea, Schlitt, Axel, Kiviniemi, Tuomas, Karjalainen, Pasi P., Lip, Gregory YH

“…Combination of oral anticoagulation (OAC) and antiplatelets is used in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention and…”
Get full text

Renal sympathetic denervation for treatment of patients with atrial fibrillation: Reappraisal of the available evidence by Nammas, Wail, PhD, Airaksinen, Juhani K.E., PhD, Paana, Tuomas, MD, Karjalainen, Pasi P., PhD

“…Afferent renal sympathetic nerve signaling regulates central sympathetic outflow. In this regard, renal sympathetic denervation has emerged as a novel…”
Get full text

Percutaneous revascularization of coronary chronic total occlusion: Toward a reappraisal of the available evidence by Karjalainen, Pasi P., PhD, Nammas, Wail, PhD

“…Abstract Chronic total occlusion (CTO) is a challenging subset of coronary artery disease that is commonly encountered in real-world practice; it is associated…”
Get full text

Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis by Daoud, Frederic C, Létinier, Louis, Moore, Nicholas, Coste, Pierre, Karjalainen, Pasi P

“…(1) Background: Practice guidelines define drug-eluting stents (DES) as the standard of care in coronary percutaneous coronary intervention (PCI), including in…”
Get full text

Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome: HATTRICK-OCT Trial by Karjalainen, Pasi P., Varho, Ville, Nammas, Wail, Mikkelsson, Jussi, Pietilä, Mikko, Ylitalo, Antti, Airaksinen, Juhani K.E., Sia, Jussi, Nyman, Kai, Biancari, Fausto, Kiviniemi, Tuomas

“…Background:Patients at high bleeding risk would benefit from a shorter dual antiplatelet therapy after PCI. Compared to first-generation devices, the design of…”
Get full text

Transcatheter leadless pacemaker implantation in a patient with a transvenous dual-chamber pacemaker already in place by Karjalainen, Pasi P., Ph.D, Nammas, Wail, Ph.D, Paana, Tuomas, M.D

“…Abstract An 83-year-old lady had a DDDR pacemaker inserted in 1997 for symptomatic atrioventricular block. She underwent battery replacement in 2008. In 2010,…”
Get full text

Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: Results From the AFCAS Registry by Lahtela, Heli, Rubboli, Andrea, Schlitt, Axel, Karjalainen, Pasi P., Niemelä, Matti, Vikman, Saila, Puurunen, Marja, Weber, Michael, Valencia, Josè, Biancari, Fausto, Lip, Gregory Y.H., Airaksinen, K.E. Juhani, for the AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting) study group

“…Background: The anti-thrombotic strategy during coronary stenting is challenging in patients on long-term oral anticoagulation (OAC) because of atrial…”
Get full text

Safety of Diagnostic Coronary Angiography During Uninterrupted Therapeutic Warfarin Treatment by Annala, Antti-Pekka, MD, Karjalainen, Pasi P., MD, PhD, Porela, Pekka, MD, PhD, Nyman, Kai, MD, Ylitalo, Antti, MD, PhD, Airaksinen, K.E. Juhani, MD, PhD

“…Long-term warfarin therapy is assumed to increase bleeding and access site complications after coronary angiography and it is often recommended to postpone…”
Get full text

Feasibility and safety of frequency-domain optical coherence tomography for coronary artery evaluation: a single-center study by Lehtinen, Tuomas, Nammas, Wail, Airaksinen, Juhani K. E., Karjalainen, Pasi P.

“…We assessed the feasibility and safety of frequency-domain optical coherence tomography (FD–OCT) in a variety of indications. We conducted a retrospective…”
Get full text

Titanium-nitride-oxide-coated coronary stents: insights from the available evidence by Karjalainen, Pasi P, Nammas, Wail

“…Coating of stent surface with a biocompatible material is suggested to improve stent safety profile. A proprietary process was developed to coat…”
Get more information

Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? by Lahtela, Heli, Karjalainen, Pasi P, Niemelä, Matti, Vikman, Saila, Kervinen, Kari, Ylitalo, Antti, Puurunen, Marja, Porela, Pekka, Nyman, Kai, Hinkka-Yli-Salomäki, Susanna, Airaksinen, K E Juhani

“…The aim of this study was to evaluate the safety of glycoprotein IIb/IIIa inhibitors (GPIs) during percutaneous coronary intervention (PCI) in patients on…”
Get more information

Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting by Airaksinen, K.E. Juhani, MD, Suurmunne, Hanna, MD, Porela, Pekka, MD, Niemelä, Matti, MD, Vikman, Saila, MD, Puurunen, Marja, MD, Annala, Antti-Pekka, MD, Biancari, Fausto, MD, Karjalainen, Pasi P., MD

“…Long-term oral anticoagulation (OAC) prevents recurrent thrombosis, pulmonary embolism, and stroke, but it also increases bleeding risk. An outpatient bleeding…”
Get full text

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence by Nammas, Wail, Koistinen, Juhani, Paana, Tuomas, Karjalainen, Pasi P

“…Heart failure syndrome results from compensatory mechanisms that operate to restore - back to normal - the systemic perfusion pressure. Sympathetic…”
Get more information

Bacterial Signatures in Thrombus Aspirates of Patients With Myocardial Infarction by PESSI, Tanja, KARHUNEN, Vesa, LAAKSONEN, Reijo, KARHUNEN, Pekka J, MIKKELSSON, Jussi, KARJALAINEN, Pasi P, YLITALO, Antti, AIRAKSINEN, Juhani K, NIEMI, Matti, PIETILA, Mikko, LOUNATMAA, Kari, HAAPANIEMI, Teppo, LEHTIMÄKI, Terho

“…Infectious agents, especially bacteria and their components originating from the oral cavity or respiratory tract, have been suggested to contribute to…”
Get full text

Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial by Tonino, Pim A L, Pijls, Nico H J, Collet, Carlos, Nammas, Wail, Van der Heyden, Jan, Romppanen, Hannu, Kervinen, Kari, Airaksinen, Juhani K E, Sia, Jussi, Lalmand, Jacques, Frambach, Peter, Penaranda, Antonio Serra, De Bruyne, Bernard, Karjalainen, Pasi P

“…This study sought to compare next-generation cobalt-chromium-based titanium-nitride-oxide (TiNO)-coated stents with a platinum-chromium-based biodegradable…”
Get full text

Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes by Sia, Jussi, Nammas, Wail, Collet, Carlos, De Bruyne, Bernard, Karjalainen, Pasi P.

“…To evaluate by optical coherence tomography neointimal healing response after implantation of cobalt-chromium-based titanium-nitride-oxide-coated (TiNO) stents…”
Get full text

Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis by Daoud, Frederic C, Catargi, Bogdan, Karjalainen, Pasi P, Gerbaud, Edouard

“…(1) Background: Percutaneous coronary interventions (PCI) in patients with acute coronary syndrome (ACS) are performed with titanium-nitride-oxide-coated…”
Get full text

One‐Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry by Rubboli, Andrea, Schlitt, Axel, Kiviniemi, Tuomas, Biancari, Fausto, Karjalainen, Pasi P., Valencia, Josè, Laine, Mika, Kirchhof, Paulus, Niemelä, Matti, Vikman, Saila, Lip, Gregory Y. H., Airaksinen, K. E. Juhani

“…ABSTRACT Background Most evidence regarding the efficacy and safety of the antithrombotic regimens for patients with atrial fibrillation (AF) undergoing…”
Get full text

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis by Jaguszewski, Milosz, Aloysius, Romila, Wang, Wei, Bezerra, Hiram G, Hill, Jonathan, De Winter, Robbert J, Karjalainen, Pasi P, Verheye, Stefan, Wijns, William, Lüscher, Thomas F, Joner, Michael, Costa, Marco, Landmesser, Ulf

“…The aim of the present study was to evaluate vascular healing of the bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr)…”
Get full text

Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study by Karjalainen, Pasi P., Mikkelsson, Jussi, Paana, Tuomas, Nammas, Wail

“…Objectives We explored the 12‐month clinical outcome of the titanium‐nitride‐oxide‐coated OPTIMAX stent based on cobalt‐chromium platform. Background: The…”
Get full text